脂肪细胞SLC7A10受损通过改变支链氨基酸代谢促进脂质储存并与胰岛素抵抗相关
研究探讨脂肪细胞SLC7A10表达降低是否通过改变促脂解氨基酸通量导致胰岛素抵抗时脂质持续积累。在脂肪细胞培养中行RNA测序和功能检测,用GC-MS/MS测定氨基酸通量,并在两个独立队列中分析人皮下脂肪组织SLC7A10 mRNA与代谢物及肥胖表型的相关性。结果显示SLC7A10受损改变支链氨基酸分解代谢和脂合成相关基因表达,增加脂肪酸摄取及支链氨基酸净摄取,并增加缬氨酸代谢物3-HIB净释放;人群队列中SLC7A10 mRNA与总脂肪量、循环甘油三酯、支链氨基酸和3-HIB呈负相关。
要点
- 脂肪细胞SLC7A10受损改变支链氨基酸分解代谢和脂合成相关基因表达。
- SLC7A10抑制增加3T3-L1脂肪细胞脂肪酸摄取及甘油和胆固醇含量。
- 人队列中SLC7A10 mRNA与总脂肪量、甘油三酯、支链氨基酸和3-HIB负相关。
核心结论
- SLC7A10活性降低强烈影响脂肪细胞支链氨基酸通量,可能为胰岛素抵抗时持续的脂合成提供燃料,并反映为循环缬氨酸衍生代谢物3-HIB水平升高。
研究设计与样本
- 在SLC7A10受损的脂肪细胞培养中进行RNA测序和相关功能检测。
- 通过靶向代谢物分析(GC-MS/MS)在人及小鼠脂肪培养中测定所有氨基酸和选定代谢物的通量。
- 在两个独立队列中分析人皮下脂肪组织SLC7A10 mRNA与候选代谢物及肥胖表型的相关性。
- 在3T3-L1脂肪细胞中研究SLC7A10抑制对脂肪酸摄取及细胞甘油和胆固醇含量的影响。
主要发现
- SLC7A10受损改变代谢过程相关基因表达,包括支链氨基酸分解代谢、脂合成和甘油异生。
- 在3T3-L1脂肪细胞中,SLC7A10抑制增加脂肪酸摄取及细胞甘油和胆固醇含量。
- 皮下脂肪组织培养中SLC7A10受损改变天冬氨酸和谷氨酸摄取,增加支链氨基酸净摄取,同时增加缬氨酸代谢物3-HIB净释放。
- 在人队列中,SLC7A10 mRNA与总脂肪量、循环甘油三酯、支链氨基酸和3-HIB呈负相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The neutral amino acid transporter SLC7A10/ASC-1 is an adipocyte-expressed gene with reduced expression in insulin resistance and obesity. Inhibition of SLC7A10 in adipocytes was shown to increase lipid accumulation despite decreasing insulin-stimulated uptake of glucose, a key substrate for de novo lipogenesis. These data imply that alternative lipogenic substrates to glucose fuel continued lipid accumulation during insulin resistance in obesity. OBJECTIVE: We examined whether increased lipid accumulation during insulin resistance in adipocytes may involve alter flux of lipogenic amino acids dependent on SLC7A10 expression and activity, and whether this is reflected by extracellular and circulating concentrations of marker metabolites. METHODS: In adipocyte cultures with impaired SLC7A10, we performed RNA sequencing and relevant functional assays. By targeted metabolite analyses (GC-MS/MS), flux of all amino acids and selected metabolites were measured in human and mouse adipose cultures. Additionally, SLC7A10 mRNA levels in human subcutaneous adipose tissue (SAT) were correlated to candidate metabolites and adiposity phenotypes in 2 independent cohorts. RESULTS: SLC7A10 impairment altered expression of genes related to metabolic processes, including branched-chain amino acid (BCAA) catabolism, lipogenesis, and glyceroneogenesis. In 3T3-L1 adipocytes, SLC7A10 inhibition increased fatty acid uptake and cellular content of glycerol and cholesterol. SLC7A10 impairment in SAT cultures altered uptake of aspartate and glutamate, and increased net uptake of BCAAs, while increasing the net release of the valine catabolite 3- hydroxyisobutyrate (3-HIB). In human cohorts, SLC7A10 mRNA correlated inversely with total fat mass, circulating triacylglycerols, BCAAs, and 3-HIB. CONCLUSION: Reduced SLC7A10 activity strongly affects flux of BCAAs in adipocytes, which may fuel continued lipogenesis during insulin resistance, and be reflected in increased circulating levels of the valine-derived catabolite 3-HIB.
引用
- Jersin RÅ, Sri Priyanka Tallapragada D, Skartveit L, et al. Impaired Adipocyte SLC7A10 Promotes Lipid Storage in Association With Insulin Resistance and Altered BCAA Metabolism. J Clin Endocrinol Metab. 2023. PMID: 36916878. doi:10.1210/clinem/dgad148
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。